Skip to main content
. Author manuscript; available in PMC: 2009 Sep 16.
Published in final edited form as: J Neurotrauma. 2008 Sep;25(9):1087–1098. doi: 10.1089/neu.2007.0444

FIG. 3.

FIG. 3

Cyp46 levels are increased at site of injury by immunohistochemistry. DAB immunostaining against Cyp46: (A) Contralateral cortex 3 days post-injury, 20×. Scale bar = 100 μm. (B) Site of injury 3 days post-injury, 20×. Scale bar = 100 μm. (C) Contralateral cortex 7 days post-injury, 20×. Scale bar = 100 μm. (D) Site of injury 7 days post-injury, 20×. Scale bar = 100 μm. Cyp46 levels appeared to be upregulated at both 3 and 7 days post-injury in comparison to contralateral cortex. (E) Sham cortex 7 days after craniotomy, 20×. Scale bar = 100 μm. Expression patterns and levels appeared similar to that seen in contralateral cortex of injured animals. (F) Secondary control staining, site of injury 7 days post-injury, 20×. Scale bar = 100 μm. No staining was visible with secondary antibody alone.